Pfam Domains GO Terms
| HECT |
| C2 |
| WW |
| positive regulation of caveolin-mediated endocytosis |
| regulation of caveolin-mediated endocytosis |
| sodium channel inhibitor activity |
| potassium channel inhibitor activity |
| negative regulation of sodium ion transmembrane transporter activity |
| negative regulation of sodium ion transmembrane transport |
| negative regulation of protein localization to cell surface |
| cellular sodium ion homeostasis |
| negative regulation of sodium ion transport |
| negative regulation of potassium ion transmembrane transporter activity |
| ventricular cardiac muscle cell action potential |
| positive regulation of dendrite extension |
| negative regulation of potassium ion transmembrane transport |
| regulation of dendrite extension |
| negative regulation of potassium ion transport |
| multivesicular body |
| sodium ion homeostasis |
| regulation of membrane repolarization |
| sodium channel regulator activity |
| regulation of protein localization to cell surface |
| cardiac muscle cell action potential involved in contraction |
| potassium channel regulator activity |
| excretion |
| cardiac muscle cell contraction |
| regulation of membrane depolarization |
| cardiac muscle cell action potential |
| protein K48-linked ubiquitination |
| regulation of sodium ion transmembrane transporter activity |
| regulation of potassium ion transmembrane transporter activity |
| protein monoubiquitination |
| regulation of sodium ion transmembrane transport |
| negative regulation of ion transmembrane transporter activity |
| water homeostasis |
| cardiac muscle contraction |
| negative regulation of transporter activity |
| regulation of potassium ion transmembrane transport |
| negative regulation of cation transmembrane transport |
| heart contraction |
| regulation of sodium ion transport |
| actin-mediated cell contraction |
| regulation of dendrite morphogenesis |
| action potential |
| regulation of potassium ion transport |
| negative regulation of ion transmembrane transport |
| heart process |
| positive regulation of endocytosis |
| cellular monovalent inorganic cation homeostasis |
| striated muscle contraction |
| actin filament-based movement |
| negative regulation of cellular protein localization |
| negative regulation of transmembrane transport |
| ion channel binding |
| monovalent inorganic cation homeostasis |
| negative regulation of ion transport |
| regulation of dendrite development |
| sodium ion transport |
| positive regulation of cell growth |
| positive regulation of developmental growth |
| viral life cycle |
| regulation of endocytosis |
| positive regulation of protein catabolic process |
| ubiquitin protein ligase activity |
| ubiquitin-protein transferase activity |
| muscle contraction |
| regulation of ion transmembrane transporter activity |
| positive regulation of growth |
| regulation of transmembrane transporter activity |
| regulation of transporter activity |
| positive regulation of neuron projection development |
| regulation of protein stability |
| protein polyubiquitination |
| muscle system process |
| regulation of cell morphogenesis involved in differentiation |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| regulation of developmental growth |
| regulation of cation transmembrane transport |
| proteasomal protein catabolic process |
| positive regulation of neuron differentiation |
| response to metal ion |
| positive regulation of cell projection organization |
| regulation of protein catabolic process |
| regulation of metal ion transport |
| blood circulation |
| circulatory system process |
| monovalent inorganic cation transport |
| regulation of cell growth |
| regulation of membrane potential |
| positive regulation of catabolic process |
| positive regulation of neurogenesis |
| regulation of ion transmembrane transport |
| negative regulation of transport |
| regulation of cell morphogenesis |
| regulation of neuron projection development |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| response to inorganic substance |
| positive regulation of nervous system development |
| regulation of cellular protein localization |
| positive regulation of cell development |
| modification-dependent macromolecule catabolic process |
| regulation of vesicle-mediated transport |
| cellular metal ion homeostasis |
| regulation of transmembrane transport |
| actin filament-based process |
| proteolysis involved in cellular protein catabolic process |
| cellular protein catabolic process |
| metal ion homeostasis |
| cellular cation homeostasis |
| metal ion transport |
| cellular ion homeostasis |
| regulation of neuron differentiation |
| regulation of growth |
| protein catabolic process |
| protein ubiquitination |
| regulation of plasma membrane bounded cell projection organization |
| regulation of ion transport |
| viral process |
| cation homeostasis |
| regulation of cell projection organization |
| inorganic ion homeostasis |
| cellular chemical homeostasis |
| protein modification by small protein conjugation |
| symbiotic process |
| ion homeostasis |
| regulation of neurogenesis |
| interspecies interaction between organisms |
| cation transport |
| negative regulation of transcription by RNA polymerase II |
| cellular homeostasis |
| cellular macromolecule catabolic process |
| regulation of cellular localization |
| regulation of nervous system development |
| regulation of cell development |
| ion transmembrane transport |
| positive regulation of cell differentiation |
| Golgi apparatus |
| protein modification by small protein conjugation or removal |
| positive regulation of transport |
| regulation of catabolic process |
| regulation of protein localization |
| macromolecule catabolic process |
| organonitrogen compound catabolic process |
| regulation of anatomical structure morphogenesis |
| chemical homeostasis |
| negative regulation of molecular function |
| negative regulation of transcription, DNA-templated |
| positive regulation of cellular component organization |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| proteolysis |
| transmembrane transport |
| negative regulation of RNA metabolic process |
| positive regulation of developmental process |
| ion transport |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| generation of neurons |
| negative regulation of biosynthetic process |
| movement of cell or subcellular component |
| neurogenesis |
| homeostatic process |
| positive regulation of protein metabolic process |
| negative regulation of gene expression |
| positive regulation of multicellular organismal process |
| organic substance catabolic process |
| cellular catabolic process |
| regulation of cell differentiation |
| regulation of transport |
| system process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 1/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Expression Distribution